Stock Market Summary – October 28, 2025

The Federal Reserve is expected to cut interest rates in its meeting this week, with markets assigning a nearly 100% probability of a quarter percentage point reduction. The interest rate is currently targeted between 4%-4.25%. Decisions will also need to be made regarding the future path of reductions and the lack of economic data.

In the tech and pharmaceutical world, Nvidia and Eli Lilly are partnering to create what they call the pharmaceutical industry’s “most powerful” supercomputer for drug development. This partnership has resulted in Nvidia’s shares rallying about 5%. Furthermore, Eli Lilly is ramping up production of its weight loss pill, orforglipron, which is expected to launch next year.

CleanSpark, a bitcoin miner, has additionally expanded into artificial intelligence (AI), developing AI data centers and recently acquiring a 100-megawatt site in Cheyenne, Wyoming, for the project.

Meanwhile, Amazon has announced its decision to cut 4% of its corporate jobs to invest in AI. However, Jim Cramer encourages investors to focus on Amazon’s cloud unit, Amazon Web Services, which he suggests will have a significant impact on lifting the stock after months of underperformance.

In terms of stocks, Cramer has highlighted a selection from San Francisco that have performed well in the past three months. These include Nektar Therapeutics, Sunrun, The RealReal and Planet Labs.

On the negative side, gold has been identified as entering correction territory due to reduced investor fears around China tensions, the Federal Reserve’s independence, and an artificial intelligence bubble. Finally, concerns have been raised regarding tense US-Chinese relations as US military officials have been asked to sign non-disclosure agreements involved with increasing operations in Latin America.


Sources: